The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus

被引:25
作者
Muscal, Eyal [1 ]
Myones, Barry L. [1 ]
机构
[1] Texas Childrens Hosp, Div Pediat Rheumatol, Houston, TX 77030 USA
关键词
pediatric lupus; anti-phospholipid antibodies; neuropsychiatric lupus; RIBOSOMAL P-PROTEINS; ANTIBODIES BIND; ONSET; MANIFESTATIONS; JUVENILE; CELLS;
D O I
10.1016/j.autrev.2006.08.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuropsychiatric syndromes are prevalent in pediatric patients with systemic lupus erythematosus (SLE) and often manifest early in disease course and with significant associated morbidity. Postulated pathogenic mechanisms of peripheral and central nervous system events include vasculopathy, autoantibody effects and systemic inflammation. The pathogenic roles of anti-phospholipid, anti-ribosomal-P and anti-neuronal autoantibodies have been examined in both focal and diffuse adult neuropsychiatric syndromes. Few studies have probed associations between these autoantibodies and pediatric neuropsychiatric SLE (NP-SLE). Retrospective review of a large ethnically diverse pediatric SLE cohort revealed anti-phospholipid, anti-ribosomal P, and anti-neuronal antibodies to be more prevalent than in many adult studies. Rates of anti-phospholipid and anti-ribosomal P antibody positivity were similar to those of other pediatric reports. Association between anti-neuronal antibodies and NP-SLE events appeared statistically significant in this cohort. Prospective inception cohort studies will need to be undertaken to investigate the significance and utility of autoantibody testing in pediatric NP-SLE. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 217
页数:3
相关论文
共 23 条
  • [1] CLINICAL, SEROLOGIC, AND IMMUNOGENETIC STUDIES IN CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS
    BARRON, KS
    SILVERMAN, ED
    GONZALES, J
    REVEILLE, JD
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 348 - 354
  • [2] CEREBROSPINAL-FLUID ANTIBODIES TO NEURONAL CELLS - ASSOCIATION WITH NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BLUESTEIN, HG
    WILLIAMS, GW
    STEINBERG, AD
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 70 (02) : 240 - 246
  • [3] Management of the neurological manifestations of APS - what do the trials tell us?
    Brey, RL
    [J]. THROMBOSIS RESEARCH, 2004, 114 (5-6) : 489 - 499
  • [4] Anti-β2-glycoprotein I antibodies bind to central nervous system
    Caronti, B
    Pittoni, V
    Palladini, G
    Valesini, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (02) : 211 - 219
  • [5] Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus
    Carreño, L
    López-Longo, FJ
    Monteagudo, I
    Rodríguez-Mahou, M
    Bascones, M
    González, CM
    Saint-Cyr, C
    Lapointe, N
    [J]. LUPUS, 1999, 8 (04) : 287 - 292
  • [6] Cassidy J T, 1977, Arthritis Rheum, V20, P315
  • [7] Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen
    Frampton, G
    Moriya, S
    Pearson, JD
    Isenberg, DA
    Ward, FJ
    Smith, TA
    Panayiotou, A
    Staines, NA
    Murphy, JJ
    [J]. RHEUMATOLOGY, 2000, 39 (10) : 1114 - 1120
  • [8] Neuropsychiatric lupus
    Ganly, JG
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (02) : 273 - +
  • [9] Hanly JG, 2003, CAN MED ASSOC J, V168, P1675
  • [10] Systemic lupus erythematosus in childhood
    Klein-Gitelman, M
    Reiff, A
    Silverman, ED
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (03) : 561 - +